115 related articles for article (PubMed ID: 9372327)
1. Elevated sialyl Lewis X-i antigen levels in pleural effusions in patients with carcinomatous pleuritis.
Ishikawa H; Satoh H; Kamma H; Naito T; Yamashita YT; Ohtsuka M; Hasegawa S
Intern Med; 1997 Oct; 36(10):685-9. PubMed ID: 9372327
[TBL] [Abstract][Full Text] [Related]
2. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K
Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864
[TBL] [Abstract][Full Text] [Related]
5. Sialyl stage-specific embryonic antigen-1: a useful marker for differentiating the etiology of pleural effusion.
Lee YC; Chern JH; Lai SL; Perng RP
Chest; 1998 Dec; 114(6):1542-5. PubMed ID: 9872185
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.
Lee SH; Park MJ; Choi SI; Lee EJ; Lee SY; In KH
Medicine (Baltimore); 2017 Jan; 96(4):e5975. PubMed ID: 28121949
[TBL] [Abstract][Full Text] [Related]
8. Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions.
Lee YC; Knox BS; Garrett JE
Aust N Z J Med; 1999 Dec; 29(6):765-9. PubMed ID: 10677119
[TBL] [Abstract][Full Text] [Related]
9. Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients.
Yamaguchi T; Kimura H; Yokota S; Yamamoto Y; Hashimoto T; Nakagawa M; Ito M; Ogura T
Jpn J Clin Oncol; 2000 Feb; 30(2):53-8. PubMed ID: 10768866
[TBL] [Abstract][Full Text] [Related]
10. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin.
Fiorelli A; Ricci S; Feola A; Mazzella A; D'Angelo L; Santini M; Di Domenico M; Di Carlo A
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):411-8. PubMed ID: 26769731
[TBL] [Abstract][Full Text] [Related]
12. Elevated progastrin-releasing peptide(31-98) concentrations in pleural effusions due to small-cell lung carcinoma.
Shijubo N; Hirasawa M; Sasaki H; Igarashi T; Fujita A; Kodama T; Yamaguchi K; Abe S
Respiration; 1996; 63(2):106-10. PubMed ID: 8966363
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
[TBL] [Abstract][Full Text] [Related]
14. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
15. Pleural effusion in lung cancer.
Sahn SA
Clin Chest Med; 1993 Mar; 14(1):189-200. PubMed ID: 8384963
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact and reliability of carbonic anhydrase XII in the differentiation of malignant and tuberculous pleural effusions.
Liu YL; Jing LL; Guo QS
Asian Pac J Cancer Prev; 2013; 14(1):351-4. PubMed ID: 23534752
[TBL] [Abstract][Full Text] [Related]
19. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Biaoxue R; Min L; Tian F; Wenlong G; Hua L
BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
Lai RS; Chen CC; Lee PC; Lu JY
Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]